This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Stocks to Watch: Apple, GE (Update 1)

Stocks in this article: VODAAPLDBDCRLHMASRLSGEUTXGOOGMMI

NEW YORK ( TheStreet) - Apple (AAPL) escalated its legal battle against Samsung by asking a California court to issue an injunction blocking sales of the Galaxy Nexus smartphone, according to reports.

In the suit, filed Wednesday in U.S. District Court in San Jose, Apple accuses Samsung of violating four Apple patents with its new phone, according to a Dow Jones report published over the weekend.

Apple argues that the new Samsung phone is the strongest competitor yet to its iPhone and poses a robust threat to its market share, Dow Jones said.

Apple shares were gaining 1.1% to $498.99 in premarket trading Monday.


U.S. conglomerate General Electric (GE) said it will hire 5,000 U.S. military veterans over the next five years and invest $580 million into growing its U.S. aviation operations in 2012.

The announcement comes ahead of a four-day meeting in Washington beginning Monday to discuss ways to jump-start the U.S. economy.

GE shares were up 0.9% to $19.05.


Internet search giant Google (GOOG) should be winning approval from European regulators and U.S. antitrust authorities for its planned $12.5 billion purchase of Motorola Mobility (MMI), Reuters reported.

Google shares were rising 0.6% to $609.78.


Vodafone (VOD), the world's largest mobile phone company, confirmed Monday it is considering making an offer for Britain's Cable & Wireless Worldwide.

Vodafone said Monday it was "in the very early stages of evaluating the merits of a potential offer for CWW."

If an offer was made, Vodafone said it likely would be in cash. Reports suggest Cable & Wireless might be sold for 700 million pounds ($1.1 billion) to 900 million pounds.

Vodafone shares were up 0.4% to $27.50.


Diebold (DBD) is expected by analysts to post fourth-quarter earnings of 84 cents a share.

Diebold, the maker of ATMS and bank vaults, will issue results before the markets open Monday. Shares were unchanged at $34.75.


Health Management Associates (HMA) is seen by analysts earning 20 cents a share in the fourth quarter on revenue of $1.58 billion.


Drug development company Charles River (CRL) is expected on Monday to post earnings of 55 cents a share in the fourth quarter, according to analysts.


Medical diagnostic control products supplier SeraCare Life Sciences (SRLS) announced that it will be acquired by an affiliate of private-equity firm Linden Capital Partners for $80.8 million, which will take the company private.

The agreement of $4 a share represents a premium of about 12% to SeraCare's Friday stock price close on the Nasdaq. The deal is expected to be completed in the second quarter.


Industrial conglomerate United Technologies (UTX) is exploring the sale of its flow and compressor businesses, which could result in a proceeds of $3.5 billion, according to Reuters.

-- Written by Joseph Woelfel and Andrea Tse



>To contact the writer of this article, click here: Andrea Tse.

>To follow the writer on Twitter, go to http://twitter.com/atwtse .

>To submit a news tip, send an email to: tips@thestreet.com.

Related links:


Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,476.57 +76.90 0.47%
S&P 500 1,924.10 +20.09 1.06%
NASDAQ 4,371.1740 +55.10 1.28%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs